These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22336853)

  • 1. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M; Dentice R
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008816. PubMed ID: 22336853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M; Dentice R
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD008816. PubMed ID: 32107770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M; Dentice R
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008816. PubMed ID: 28146603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R; Elkins M
    Cochrane Database Syst Rev; 2011 May; (5):CD007923. PubMed ID: 21563162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R; Elkins M
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD007923. PubMed ID: 27457496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebulised hypertonic saline for cystic fibrosis.
    Wark P; McDonald VM
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001506. PubMed ID: 30260472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R; Elkins M
    Cochrane Database Syst Rev; 2013 Jun; (6):CD007923. PubMed ID: 23737088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R; Elkins M
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007923. PubMed ID: 33686652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R; Elkins M
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD007923. PubMed ID: 30480755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2000; (2):CD001506. PubMed ID: 10796798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulised hypertonic saline for cystic fibrosis.
    Wark P; McDonald VM; Smith S
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD001506. PubMed ID: 37319354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V; Jones AP
    Cochrane Database Syst Rev; 2005 Jul; (3):CD001506. PubMed ID: 16034863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2003; (1):CD001506. PubMed ID: 12535409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial.
    Dentice RL; Elkins MR; Bye PT
    J Physiother; 2012; 58(1):33-40. PubMed ID: 22341380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled mannitol for cystic fibrosis.
    Nolan SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008649. PubMed ID: 26451533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oscillating devices for airway clearance in people with cystic fibrosis.
    Morrison L; Innes S
    Cochrane Database Syst Rev; 2017 May; 5(5):CD006842. PubMed ID: 28471492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oscillating devices for airway clearance in people with cystic fibrosis.
    Morrison L; Milroy S
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD006842. PubMed ID: 32352564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
    Tam J; Nash EF; Ratjen F; Tullis E; Stephenson A
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007168. PubMed ID: 23852992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
    Nash EF; Stephenson A; Ratjen F; Tullis E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007168. PubMed ID: 19160327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulised hypertonic saline for cystic fibrosis.
    Wark P; McDonald VM
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001506. PubMed ID: 19370568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.